107 related articles for article (PubMed ID: 38718786)
1. Exhaled breath analysis in patients with potentially curative lung cancer undergoing surgery: a longitudinal study.
Herth J; Schmidt F; Basler S; Sievi NA; Kohler M
J Breath Res; 2024 May; 18(3):. PubMed ID: 38718786
[TBL] [Abstract][Full Text] [Related]
2. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of lung cancer by analysis of exhaled breath.
Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A
BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722
[TBL] [Abstract][Full Text] [Related]
4. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
5. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
6. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
7. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
[TBL] [Abstract][Full Text] [Related]
8. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of lung cancer using exhaled breath.
Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M
Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867
[TBL] [Abstract][Full Text] [Related]
10. Exhaled gases online measurements for esophageal cancer patients and healthy people by proton transfer reaction mass spectrometry.
Zou X; Zhou W; Lu Y; Shen C; Hu Z; Wang H; Jiang H; Chu Y
J Gastroenterol Hepatol; 2016 Nov; 31(11):1837-1843. PubMed ID: 26996099
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
13. Exhaled breath condensate biomarkers for lung cancer.
Campanella A; De Summa S; Tommasi S
J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
[TBL] [Abstract][Full Text] [Related]
14. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
15. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer biomarkers in exhaled breath.
Amann A; Corradi M; Mazzone P; Mutti A
Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
[TBL] [Abstract][Full Text] [Related]
17. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
19. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
20. Exhaled breath biopsy: a new cancer detection paradigm.
Abderrahman B
Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
[No Abstract] [Full Text] [Related]
[Next] [New Search]